|
|
||||||||
MUCOSAL BIOLOGY
Departments of 1Surgery, 2Medicine, and 3Cell and Molecular Physiology, University of North Carolina, Chapel Hill, North Carolina; and 4Michael E. DeBakey Department of Surgery and Departments of 5Pediatrics and 6Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas
Submitted 16 May 2007 ; accepted in final form 12 September 2007
Sustained increases in mucosal surface area occur in remaining bowel following massive intestinal loss. The mechanisms responsible for expanding and perpetuating this response are not presently understood. We hypothesized that an increase in the number of intestinal stem cells (ISC) occurs following intestinal resection and is an important component of the adaptive response in mice. This was assessed in the jejunum of mice 2–3 days, 4–5 days, 6–7 days, 2 wk, 6 wk, and 16 wk following ileocecal resection (ICR) or sham operation. Changes in ISC following ICR compared with sham resulted in increased crypt fission and were assayed by 1) putative ISC population (SP) by flow cytometry, 2) Musashi-1 immunohistochemistry, and 3) bromodeoxyuridine (BrdU) label retention. Observed early increases in crypt depth and villus height were not sustained 16 wk following operation. In contrast, long-term increases in intestinal caliber and overall number of crypts per circumference appear to account for the enhanced mucosal surface area following ICR. Flow cytometry demonstrated that significant increases in SP cells occur within 2–3 days following resection. By 7 days, ICR resulted in marked increases in crypt fission and Musashi-1 immunohistochemistry staining. Separate label-retention studies confirmed a 20-fold increase in BrdU incorporation 6 wk following ICR, confirming an overall increase in the number of ISC. These studies support that expansion of ISC occurs following ICR, leading to an overall increase number of crypts through a process of fission and intestinal dilation. Understanding the mechanism expanding ISCs may provide important insight into management of intestinal failure.
intestinal stem cells; intestinal resection; crypt fission; label retention
This article has been cited by other articles:
![]() |
C. M. Dekaney, A. S. Gulati, A. P. Garrison, M. A. Helmrath, and S. J. Henning Regeneration of intestinal stem/progenitor cells following doxorubicin treatment of mice Am J Physiol Gastrointest Liver Physiol, September 1, 2009; 297(3): G461 - G470. [Abstract] [Full Text] [PDF] |
||||
![]() |
R J Rigby, M R Hunt, B P Scull, J G Simmons, K E Speck, M A Helmrath, and P K Lund A new animal model of postsurgical bowel inflammation and fibrosis: the effect of commensal microflora Gut, August 1, 2009; 58(8): 1104 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Joly, C. Mayeur, B. Messing, A. Lavergne-Slove, D. Cazals-Hatem, M.-L. Noordine, C. Cherbuy, P.-H. Duee, and M. Thomas Morphological adaptation with preserved proliferation/transporter content in the colon of patients with short bowel syndrome Am J Physiol Gastrointest Liver Physiol, July 1, 2009; 297(1): G116 - G123. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Garrison, C. M. Dekaney, D. C. von Allmen, P. K. Lund, S. J. Henning, and M. A. Helmrath Early but not late administration of glucagon-like peptide-2 following ileo-cecal resection augments putative intestinal stem cell expansion Am J Physiol Gastrointest Liver Physiol, March 1, 2009; 296(3): G643 - G650. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Geske, X. Zhang, K. K. Patel, D. M. Ornitz, and T. S. Stappenbeck Fgf9 signaling regulates small intestinal elongation and mesenchymal development Development, September 1, 2008; 135(17): 2959 - 2968. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |